DR. STEPHEN GARRETT MARCUS, M.D.
Osteopathic Medicine at Bell Tower Ln, Fort Lauderdale, FL
License number
Florida C-38904
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1792 Bell Tower Ln, Fort Lauderdale, FL 33326
Phone
(954) 315-3660
(954) 315-3661 (Fax)
(954) 315-3661 (Fax)
Personal information
See more information about STEPHEN GARRETT MARCUS at radaris.comName
Address
Phone
5455 Edgerton Ave, Lake Worth, FL 33463
519 NE 118Th St, Biscayne Park, FL 33161
7440 SW 5Th St, Plantation, FL 33317
17843 Lake Estates Dr, Boca Raton, FL 33496
10 Ryewood Cir, Homosassa, FL 34446
Professional information
Dr. Stephen G Marcus, Fort Lauderdale FL - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
1792 Bell Tower Ln, Fort Lauderdale 33326
(954) 315-3660 (Phone), (954) 315-3661 (Fax)
(954) 315-3660 (Phone), (954) 315-3661 (Fax)
Certifications:
Internal Medicine, 1980
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
New York Medical College
Graduated: 1976
Lenox Hill Hospital
University Of California-San Francisco
New York Medical College
Graduated: 1976
Lenox Hill Hospital
University Of California-San Francisco
Stephen Garrett Marcus, Weston FL
Specialties:
Internist
Address:
1792 Bell Tower Ln, Weston, FL 33326
Sensitization Of Cancer Cells To Treatment
US Patent:
2012019, Aug 2, 2012
Filed:
Jan 31, 2012
Appl. No.:
13/363185
Inventors:
Stephen MARCUS - Weston FL, US
Assignee:
ParinGenix, Inc. - Weston FL
International Classification:
A61K 31/727, A61P 35/00, A61K 31/7068
US Classification:
514 49, 514 56
Abstract:
The present application provides methods for the treatment of cancer, comprising administering substantially non-anticoagulant 2-O, 3-O desulfated heparin to patients suffering from cancer that is, or can become resistant to, cancer treatment, such as chemotherapy, targeted cancer therapy, or radiation therapy. The compositions can be administered to sensitize, or to reverse resistance to, cancer treatment, and can be administered alone or in combination with cancer treatment to subjects with solid tumors including, but not limited to, pancreatic, breast, renal, colorectal, gastric, or esophageal cancer, and subjects with hematologic malignancies, including but not limited to leukemia and lymphoma.
Treatment Of Myelosuppression
US Patent:
2013032, Dec 5, 2013
Filed:
Aug 9, 2013
Appl. No.:
13/963526
Inventors:
Stephen MARCUS - Weston FL, US
Assignee:
ParinGenix, Inc. - Weston FL
International Classification:
A61K 31/727, A61K 39/395, A61N 5/00, A61K 35/28
US Classification:
4241301, 514 56, 424577, 600 1
Abstract:
Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids.
Treatment Of Myelosuppression
US Patent:
2013030, Nov 14, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/801990
Inventors:
Stephen MARCUS - Weston FL, US
International Classification:
A61K 31/727
US Classification:
514 56
Abstract:
Methods are presented for attenuating myelosuppressive side effects of treatment regimens, promoting thrombopoiesis and neutrophil production, and increasing efficacy of treatment regimens, by administering PF4-interacting heparinoids.
Osteopathic Medicine licenses in Florida
JEAN-CLAUDE NERETTE, Osteopathic Medicine, 2665 Executive Park Dr SUITE 3, Fort Lauderdale, FL 33331